Drug Shortage Report for CLADRIBINE INJECTION
| Report ID | 220112 |
| Drug Identification Number | 02494574 |
| Brand name | CLADRIBINE INJECTION |
| Common or Proper name | CLADRIBINE INJECTION |
| Company Name | GENERIC MEDICAL PARTNERS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLADRIBINE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1mg/ml 10ml Vial |
| ATC code | L01BB |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-01-25 |
| Actual start date | 2024-01-25 |
| Estimated end date | 2024-02-26 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-02-21 |
| Company comments | It was expected that GMP Cladribine 1mg/ml 10 ml vials would be available for sale from mid-February 2024. A short delay will occur before GMP Cladribine 1mg/ml 10 ml vials will be released. It is now expected that stock will be available for sale from February 26 2024. A communication will be issued on the actual day of release. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-02-21 | French | Compare |
| v1 | 2024-02-21 | English | Compare |
Showing 1 to 2 of 2